MarketPeel
Insider Trading Intelligence
Pricing
…
RS

Richard Scott Struthers

CRNX
PRESIDENT & CEO · CRINETICS PHARMACEUTICALS, INC. · CIK 0001746298
FILING MIX · LIFETIME43%/57%
BUYS
31
SELLS
41
TOTAL VALUE
$26.45M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
112,100
AVG SELL PX
$32.99
TRADE KIND
SHOWING 72 / 72
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 11 pending
Forward-return performance of every backtestable P/S trade by Richard Scott Struthers, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+95.00%-5.65%+0.06%-5.71%-4.93%—
14d20+100.00%-7.71%-1.07%-6.64%-5.38%—
30d20+70.00%-6.84%-0.55%-6.29%-5.36%—
60d20+65.00%-7.15%+1.53%-8.69%-10.78%—
90d20+70.00%-1.67%+2.29%-3.96%-3.60%—
180d20(2 pending)+72.22%+0.92%+4.66%-3.74%-19.48%—
1y20(3 pending)+58.82%+17.17%+14.17%+3.00%-13.37%—
2y20(6 pending)+35.71%+35.38%+27.64%+7.74%+15.42%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRNX · 112,100 shares · as of May 29, 2026
0227,076454,153681,229908,305202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 31 buys / 41 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
222,200——223,200May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
222,200——626,978May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
111,100——111,100May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
111,100——515,878May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
111,100——404,778May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
111,100——1,000May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
111,100——112,100May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
222,200——216,805May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
222,200——439,005May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
80,000——136,805May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
80,000——80,000May 29, 2026Jun 2, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
8,785$37.77$331.8K404,778Mar 16, 2026Mar 18, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
13,196$37.11$489.7K413,563Mar 16, 2026Mar 18, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
62,000——426,759Feb 23, 2026Feb 25, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
228,000——228,000Feb 23, 2026Feb 25, 2026 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
28,400$15.29$434.2K364,759Dec 18, 2025Dec 18, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
28,400——259,058Dec 18, 2025Dec 18, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
16,342——0Dec 18, 2025Dec 18, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
16,342$9.28$151.7K336,359Dec 18, 2025Dec 18, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,000$45.00$180.0K106,000Sep 26, 2025Sep 30, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
90,400——320,017May 14, 2025May 16, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
90,400——661,205May 14, 2025May 16, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
81,270——0Apr 2, 2025Apr 4, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
81,270$1.91$155.2K410,417Apr 2, 2025Apr 4, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
16,463$34.17$562.5K330,022Mar 19, 2025Mar 21, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
875$34.83$30.5K329,147Mar 19, 2025Mar 21, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
89,000——346,485Feb 20, 2025Feb 24, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
313,000——313,000Feb 20, 2025Feb 24, 2025 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
10,000$57.57$575.7K100,000Dec 2, 2024Dec 4, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
107,448$49.40$5.31M257,485May 8, 2024May 10, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
107,448$9.28$997.1K364,933May 8, 2024May 10, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
107,448——16,342May 8, 2024May 10, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
350——257,485Apr 18, 2024Apr 22, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
20,000——81,270Apr 15, 2024Apr 17, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
20,000$1.91$38.2K257,835Apr 15, 2024Apr 17, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
40,951$9.28$380.0K278,786Apr 4, 2024Apr 8, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
40,951$49.17$2.01M237,835Apr 4, 2024Apr 8, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
40,951——123,790Apr 4, 2024Apr 8, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
12,687$38.14$483.9K237,835Mar 18, 2024Mar 20, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
240,000——240,000Mar 4, 2024Mar 6, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
65,000——250,522Mar 4, 2024Mar 6, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Gift
20,000——110,000Feb 12, 2024Feb 14, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALEGRANT
Gift
60,000——570,805Feb 12, 2024Feb 14, 2024 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
50,000$1.91$95.5K185,522Nov 9, 2023Nov 13, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
50,000——101,270Nov 9, 2023Nov 13, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
199,082$9.28$1.85M334,604Nov 3, 2023Nov 6, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
199,082——164,741Nov 3, 2023Nov 6, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
199,082$30.56$6.08M135,522Nov 3, 2023Nov 6, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
918——363,823Nov 2, 2023Nov 6, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
918$29.95$27.5K135,522Nov 2, 2023Nov 6, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
918$9.28$8.5K136,440Nov 2, 2023Nov 6, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
10,000——151,270Aug 14, 2023Aug 16, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
10,000$1.91$19.1K135,522Aug 14, 2023Aug 16, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
50,000$20.81$1.04M680,805Jun 16, 2023Jun 21, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
4,628$17.12$79.2K125,522Mar 16, 2023Mar 17, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
61,650——130,150Mar 1, 2023Mar 3, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
287,700——287,700Mar 1, 2023Mar 3, 2023 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
11,100——161,270Oct 12, 2022Oct 14, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
11,100$1.91$21.2K68,500Oct 12, 2022Oct 14, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
69,176$27.53$1.90M730,805Apr 13, 2022Apr 15, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
44,793$26.52$1.19M799,981Apr 13, 2022Apr 15, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
24,674$25.42$627.3K844,774Apr 13, 2022Apr 15, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
21,357$25.34$541.2K869,448Apr 5, 2022Apr 7, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
249,200——249,200Feb 28, 2022Mar 2, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
53,400——57,400Feb 28, 2022Mar 2, 2022 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
10,000$25.00$250.0K90,000Sep 7, 2021Sep 9, 2021 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
294,000——294,000Feb 26, 2021Mar 2, 2021 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
4,000$13.10$52.4K4,000Dec 3, 2020Dec 4, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASE
President & CEO
1,000$12.60$12.6K1,000Dec 2, 2020Dec 4, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
17,500$14.46$253.1K890,805Jul 16, 2020Jul 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
President & CEO
17,500$15.30$267.7K908,305Jul 15, 2020Jul 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
200,000——200,000Feb 24, 2020Feb 26, 2020 ↗View →
Other insiders · CRNX
Loading peer insiders…
About this filer
CIK 0001746298
ROLE
President & CEO
PRIMARY
CRNX
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001746298DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback